Ragon Institute

Study offers new way to discover HIV vaccine targetsRagon Institute researchers develop a method to identify weak points in viral proteins that could be exploited for vaccine development.

Bringing a new perspective to infectious diseaseEnlisted in the fight against HIV, MIT engineers and scientists contribute new technology, materials and computational studies.

Monitoring how T cells respond to HIVNew technology could help AIDS researchers develop new vaccines.

Scientists reveal HIV weaknessVaccines that target newly identified viral protein sequences could be more effective than previous efforts.

New insights into the mystery of natural HIV immunityA new finding from the Ragon Institute of MGH, MIT and Harvard may have implications for designing an effective AIDS vaccine.

3 Questions: AIDS researchers on new vaccine resultsPartial success of a new AIDS vaccine offers clues to help develop a stronger vaccine, say MIT’s Arup Chakraborty and MGH’s Bruce Walker.